Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00459537
Status:
COMPLETED
Last Update Posted:
2011-05-06
First Post:
2007-04-10
Brief Title:
Efficacy Safety and Tolerability of Topical 10 Terbinafine Hydrogen Chloride Versus 5 Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Randomized Open-label Active-controlled Multicenter Parallel Group Study to Assess the Efficacy Safety and Tolerability of Topical 10 Terbinafine Hydrogen Chloride HCl Formulation Versus 5 Amorolfine Nail Lacquer for 48 Weeks of Treatment in Patients With Mild to Moderate Toenail Onychomycosis
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the efficacy safety and tolerability of topical 10 terbinafine hydrogen chloride applied daily versus 5 amorolfine nail lacquer applied twice a week in patients with mild to moderate toenail onychomycosis for a total treatment duration of 48 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None